shRNA knockdown of BCL3 in breast cancer cells with concomitant TGF-β stimulation, revealed decreased SMAD3 phosphorylation, decreased SMAD3 protein levels and attenuated TGF-β reporter luciferase assay activity [14]. Here, SMAD3 is linked to breast cancer.